[1] Angers M, Uldry M, Kong D, et al. Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis[J]. Biochem J, 2008, 416(3): 347-355. [2] Colombo F, Falvella F S, Galvan A, et al. A 5′-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A[J]. Mol Cancer, 2011, 10: 81. [3] Spinola M, Falvella F S, Colombo F, et al. MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment[J]. Mol Cancer, 2010, 9: 62. [4] Liang C Y, Wang L J, Chen C P, et al. GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta[J]. Biol Reprod, 2010, 83(3): 387-395. [5] Berger J H, Charron M J, Silver D L. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism[J]. Plos One, 2012, 7(11): e50629. [6] Ben-Zvi A, Lacoste B, Kur E, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier[J]. Nature, 2014, 509(7501): 507-511. [7] Nguyen L N, Ma D L, Shui G H, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid[J]. Nature, 2014, 509(7501): 503-507. [8] Spinola M, Falvella F S, Galvan A, et al. Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival[J]. Lung Cancer, 2007, 55(3): 271-277. [9] Spinola M, Galvan A, Pignatiello C, et al. Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer[J]. Oncogene, 2005, 24(35): 5502-5509. [10] Chen S Q, Zheng Z H, Tang J Q, et al. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population[J]. Carcinogenesis, 2013, 34(5): 1018-1024. [11] Shi X, Huang Y M, Wang H Y, et al. MFSD2A expression predicts better prognosis in gastric cancer[J]. Biochem Biophys Res Commun, 2018, 505(3): 699-704. [12] Arvidsson G, Henriksson J, Sander B, et al. Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients[J]. Haematologica, 2018, 103(4): 666-678. [13] Pu W J, Zhang H, Huang X Z, et al. Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration[J]. Nat Commun, 2016, 7:13369. [14] Baglieri J, Brenner D A, Kisseleva T. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma[J]. Int J Mol Sci, 2019, 20(7): 1723. [15] 王卫兵,徐骁,郑树森. 酒精相关性肝癌研究进展[J]. 中华普通外科杂志, 2012, 27(2): 173-175. [16] 尉洪龙,王付海,修鹏,等.肝细胞癌组织缺氧诱导因子2α表达及其临床意义[J].中华肿瘤防治杂志,2018,25(17):1222-1226. [17] 鲁磊,肖开银,朱广志,等.原发性肝细胞癌根治术后行肝动脉化疗栓塞术生存分析[J].中华肿瘤防治杂志,2018,25(4):263-269. [18] 蒋保三,赵洪波,朱亚玲,等.泛素结合酶E2S在肝细胞肝癌中的表达及其与预后的关系[J].中国医科大学学报,2019,48(10):915-918,925. [19] Xing S, Kan J, Su A S, et al. The prognostic value of major facilitator superfamily domain-containing protein 2A in patients with hepatocellular carcinoma[J]. Aging, 2019, 11(19): 8474-8483. |